Main Industry
Biotechnology
Main Product/Service
1. Technology Platform
2. 505(b)(2) NDA
3. High Barrier ANDA
2. 505(b)(2) NDA
3. High Barrier ANDA
Founded Year
2014
Unified Business No.
24546157
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,587,831,000 (NT$)
Location of Company
Taiwan
, Tainan City
Exit Status
Emerging Stock Exchange(2016)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of niche portfolios. The company’s business strategy comprises utilizing our Taiwan headquarter as our global R&D center and establishing our presence in the world’s two largest pharmaceutical markets (the US and China).
We specialize in controlled-release technology and products that are difficult to formulate. Our business model includes managing all aspects of the product development process through the submission of its 505(b)(2) New Drug Applications (NDA) and High barrier-Abbreviated New Drug Applications (ANDA) to the United States Food and Drug Administration (FDA).
We specialize in controlled-release technology and products that are difficult to formulate. Our business model includes managing all aspects of the product development process through the submission of its 505(b)(2) New Drug Applications (NDA) and High barrier-Abbreviated New Drug Applications (ANDA) to the United States Food and Drug Administration (FDA).
